ANTX Stock Analysis: Buy, Sell, or Hold?
ANTX - AN2 Therapeutics, Inc. Common Stock
$4.90
0.14 (2.94%)
▲
5d:
+16.67%
30d:
+9.37%
90d:
+6.06%
BUY
MODERATE Confidence
Analysis Updated: Jun 17, 2026 12:00 AM ET
Earnings: May 12, 2026
0d
Get Alerted When ANTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ANTX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: ANTX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: ANTX is currently trading at $4.90, which is considered extended relative to its 30-day fair value range of $4.14 to $4.78.
Technical Outlook: Technically, ANTX is in a strong uptrend. Immediate support is located at $3.70, while resistance sits at $5.08.
Market Sentiment: ANTX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $9.00 (+83.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ANTX is in a strong uptrend. Immediate support is located at $3.70, while resistance sits at $5.08.
Market Sentiment: ANTX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $9.00 (+83.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$4.14 -
$4.78
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 83.7% below Wall St target ($9.00)
Trading Range Analysis
30-Day Trading Range
$4.14 -
$4.78
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$3.70
Resistance Level
$5.08
Current Trend
Strong Uptrend
Technical data as of
Jun 17, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.71
Wall Street Target
$9.00
(+83.7%)
Share & Embed Analysis
Last updated: June 17, 2026 5:48 PM ET
Data refreshes hourly during market hours. Next update: 6:48 PM
Data refreshes hourly during market hours. Next update: 6:48 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ANTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
9
Sells
Net
INSIDERS SELLING
Recent Transactions
Sarah Joanne Williams
SELL
327 shares
2026-03-03
Joshua M Eizen
SELL
6931 shares
2026-01-06
Lucy Day
SELL
5512 shares
2026-01-06
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1029 | 61 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 55 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 53 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$297 | 56 HOLD |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$51 | 61 BUY |
